David J. Birnkrant

8.4k total citations · 5 hit papers
61 papers, 5.4k citations indexed

About

David J. Birnkrant is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, David J. Birnkrant has authored 61 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 23 papers in Pulmonary and Respiratory Medicine and 17 papers in Genetics. Recurrent topics in David J. Birnkrant's work include Muscle Physiology and Disorders (30 papers), Neurogenetic and Muscular Disorders Research (17 papers) and Respiratory Support and Mechanisms (16 papers). David J. Birnkrant is often cited by papers focused on Muscle Physiology and Disorders (30 papers), Neurogenetic and Muscular Disorders Research (17 papers) and Respiratory Support and Mechanisms (16 papers). David J. Birnkrant collaborates with scholars based in United States, United Kingdom and Canada. David J. Birnkrant's co-authors include K. Bushby, Laura E. Case, Linda Cripe, Shree Pandya, Jean Tomezsko, Paula R. Clemens, Kathi Kinnett, James Poysky, Craig M. McDonald and Frederic Shapiro and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, PEDIATRICS and The Lancet Neurology.

In The Last Decade

David J. Birnkrant

60 papers receiving 5.3k citations

Hit Papers

Diagnosis and management of Duchenne muscular dystrophy, ... 2009 2026 2014 2020 2009 2009 2018 2018 2018 400 800 1.2k

Peers

David J. Birnkrant
Linda Cripe United States
K. Bushby United Kingdom
Jean Tomezsko United States
Michelle Eagle United Kingdom
Laura E. Case United States
Shree Pandya United States
Kathi Kinnett United States
Richard T. Abresch United States
Julaine Florence United States
Linda Cripe United States
David J. Birnkrant
Citations per year, relative to David J. Birnkrant David J. Birnkrant (= 1×) peers Linda Cripe

Countries citing papers authored by David J. Birnkrant

Since Specialization
Citations

This map shows the geographic impact of David J. Birnkrant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Birnkrant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Birnkrant more than expected).

Fields of papers citing papers by David J. Birnkrant

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David J. Birnkrant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Birnkrant. The network helps show where David J. Birnkrant may publish in the future.

Co-authorship network of co-authors of David J. Birnkrant

This figure shows the co-authorship network connecting the top 25 collaborators of David J. Birnkrant. A scholar is included among the top collaborators of David J. Birnkrant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David J. Birnkrant. David J. Birnkrant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Birnkrant, David J.. (2025). The importance of better natural history studies for Duchenne muscular dystrophy. Developmental Medicine & Child Neurology. 67(10). 1241–1242. 1 indexed citations
2.
Birnkrant, David J., et al.. (2024). A New Perspective on Drugs for Duchenne Muscular Dystrophy: Proposals for Better Respiratory Outcomes and Improved Regulatory Pathways. Pediatric Drugs. 27(2). 143–159. 3 indexed citations
3.
Birnkrant, David J., Luca Bello, Russell J. Butterfield, et al.. (2022). Cardiorespiratory management of Duchenne muscular dystrophy: emerging therapies, neuromuscular genetics, and new clinical challenges. The Lancet Respiratory Medicine. 10(4). 403–420. 17 indexed citations
4.
Sheehan, Daniel W., et al.. (2018). Muscular Dystrophies. Clinics in Chest Medicine. 39(2). 377–389. 54 indexed citations
5.
Birnkrant, David J., K. Bushby, Carla Bann, et al.. (2018). Diagnosis and management of Duchenne muscular dystrophy, part 3: primary care, emergency management, psychosocial care, and transitions of care across the lifespan. The Lancet Neurology. 17(5). 445–455. 278 indexed citations breakdown →
6.
Birnkrant, David J., K. Bushby, Carla Bann, et al.. (2018). Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management. The Lancet Neurology. 17(3). 251–267. 781 indexed citations breakdown →
7.
Birnkrant, David J., K. Bushby, Carla Bann, et al.. (2018). Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management. The Lancet Neurology. 17(4). 347–361. 651 indexed citations breakdown →
8.
Finder, Jonathan D., Oscar H. Mayer, Daniel W. Sheehan, et al.. (2017). Pulmonary Endpoints in Duchenne Muscular Dystrophy. A Workshop Summary. American Journal of Respiratory and Critical Care Medicine. 196(4). 512–519. 33 indexed citations
9.
Birnkrant, David J., Mahi L. Ashwath, Garey Noritz, et al.. (2010). Cardiac and Pulmonary Function Variability in Duchenne/Becker Muscular Dystrophy: An Initial Report. Journal of Child Neurology. 25(9). 1110–1115. 24 indexed citations
10.
Bushby, K., Richard S. Finkel, David J. Birnkrant, et al.. (2009). Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. The Lancet Neurology. 9(1). 77–93. 1378 indexed citations breakdown →
11.
Shah, Tushar A., et al.. (2008). Symptomatic nephrolithiasis in prolonged survivors of Duchenne muscular dystrophy. Neuromuscular Disorders. 18(7). 561–564. 18 indexed citations
12.
O’Brien, Jane E., Helene M. Dumas, Stephen M. Haley, et al.. (2007). Ventilator weaning outcomes in chronic respiratory failure in children. International Journal of Rehabilitation Research. 30(2). 171–174. 10 indexed citations
13.
Birnkrant, David J., et al.. (2006). Use of the laryngeal mask airway in patients with severe muscular dystrophy who require sedation or anesthesia. Pediatric Pulmonology. 41(11). 1077–1081. 8 indexed citations
14.
15.
Finder, Jonathan D., David J. Birnkrant, John Carl, et al.. (2004). Respiratory Care of the Patient with Duchenne Muscular Dystrophy. American Journal of Respiratory and Critical Care Medicine. 170(4). 456–465. 484 indexed citations
16.
Birnkrant, David J., et al.. (2000). Use of Bronchoalveolar Lavage to Demonstrate Squamous Epithelial Aspiration in Congenital Icthyosis: A Case Report. Journal of Perinatology. 20(5). 329–330. 2 indexed citations
17.
Birnkrant, David J., et al.. (1998). Treatment of Type I Spinal Muscular Atrophy With Noninvasive Ventilation and Gastrostomy Feeding. Pediatric Neurology. 18(5). 407–410. 65 indexed citations
18.
Birnkrant, David J., et al.. (1997). Noninvasive ventilation during percutaneous gastrostomy placement in Duchenne muscular dystrophy. Pediatric Pulmonology. 23(6). 468–471. 15 indexed citations
19.
Birnkrant, David J., et al.. (1996). Persistent pulmonary consolidation treated with intrapulmonary percussive ventilation: A preliminary report. Pediatric Pulmonology. 21(4). 246–249. 56 indexed citations
20.
Birnkrant, David J., Scott L. Mader, Erik van Lunteren, & Pamela B. Davis. (1991). Chronic hypoxia increases β-adrenergic receptor density in the lungs of young and old rats. Mechanisms of Ageing and Development. 60(2). 135–142. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026